MICRO LABS FDA Approval ANDA 209929

ANDA 209929

MICRO LABS

FDA Drug Application

Application #209929

Application Sponsors

ANDA 209929MICRO LABS

Marketing Status

Prescription001

Application Products

001CAPSULE, EXTENDED RELEASE;ORAL25MG;200MG0ASPIRIN AND DIPYRIDAMOLEASPIRIN; DIPYRIDAMOLE

FDA Submissions

UNKNOWN; ORIG1AP2021-08-11STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

MICRO LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209929
            [companyName] => MICRO LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"ASPIRIN AND DIPYRIDAMOLE","activeIngredients":"ASPIRIN; DIPYRIDAMOLE","strength":"25MG;200MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/11\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-08-11
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.